[
  {
    "ts": null,
    "headline": "CRL Q1 Earnings Call: Regulatory Changes and Market Stabilization Shape Outlook",
    "summary": "Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 2.7% year on year to $984.2 million. Its non-GAAP profit of $2.34 per share was 12.8% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=78c990da30b7c3e755e4f2d4403e622b5c1ea2621aefa773b8369ce524a10ea5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749634124,
      "headline": "CRL Q1 Earnings Call: Regulatory Changes and Market Stabilization Shape Outlook",
      "id": 135180820,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 2.7% year on year to $984.2 million. Its non-GAAP profit of $2.34 per share was 12.8% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=78c990da30b7c3e755e4f2d4403e622b5c1ea2621aefa773b8369ce524a10ea5"
    }
  }
]